Oxbow Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
|
+$70M |
| 2 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$25.8M |
| 3 |
iShares Silver Trust
SLV
|
+$7.66M |
| 4 |
Newmont
NEM
|
+$5.23M |
| 5 |
Gilead Sciences
GILD
|
+$4.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$14.1M |
| 2 |
UnitedHealth
UNH
|
+$7.85M |
| 3 |
Nike
NKE
|
+$6.58M |
| 4 |
Northern Oil and Gas
NOG
|
+$5.65M |
| 5 |
EOG Resources
EOG
|
+$5.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.34% |
| 2 | Technology | 11.88% |
| 3 | Healthcare | 6% |
| 4 | Materials | 5.87% |
| 5 | Financials | 5.56% |
Similar funds
Oxbow Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Oxbow Advisors held 248 positions worth $852M, up 17% from $728M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Oxbow Advisors deployed $110M of net new capital in Q2 2024, opening 25 new positions and adding to 82 existing holdings. Its largest new stake was Vanguard World Funds Extended Duration ETF: 356,714 shares worth $26.2M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Treasury Floating Rate Bond ETF, an estimated $14.1M trimmed.
- Oxbow Advisors's largest Q2 2024 buy was Vanguard World Funds Extended Duration ETF: 356,714 shares worth $26.2M.
- Oxbow Advisors added most to F/m US Treasury 3 Month Bill Fund in Q2 2024, an estimated $70M increase.
- Oxbow Advisors's biggest Q2 2024 reduction was iShares Treasury Floating Rate Bond ETF, cutting an estimated $14.1M.
- Oxbow Advisors fully exited Nike in Q2 2024, selling an estimated $6.58M.
- Oxbow Advisors's ten largest holdings make up 45% of its $852M portfolio in Q2 2024.
- Oxbow Advisors opened 25 new positions and closed 18 in Q2 2024.
- Oxbow Advisors's portfolio value rose 17% quarter-over-quarter to $852M.
Based on Oxbow Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.